Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Pediatric and Adolescent Gynecology
|
December 15, 2016
Clinical Recommendation: Vulvovaginitis
Andrea Zuckerman, Mary Romano
The American Journal of Geriatric Pharmacotherapy
|
August 5, 2008
Cardiovascular risk factors and dementia
Howard Fillit, David T Nash, Tatjana Rundek, et al.
Journal of the Cardiometabolic Syndrome
|
September 6, 2007
Atorvastatin does not induce glomerular or tubular dysfunction even at high doses
Murray Epstein, Elizabeth Leary, Rachel Laskey, et al.
Journal of the American Society of Nephrology : JASN
|
July 23, 2003
Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP
Praveen N Chander, Ricardo Rocha, Jeffrey Ranaudo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 14, 2009
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD
Michael J Koren, Michael H Davidson, Daniel J Wilson, et al.
Fertility and Sterility
|
September 28, 2021
Iconic brands: standing the test of time with a little rebranding
Steven R Lindheim, Samantha M Pfeifer, Beth W Rackow, et al.
Seminars in Arthritis and Rheumatism
|
April 16, 2016
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist
Christina Charles-Schoeman, Miguel A Gonzalez-Gay, Irina Kaplan, et al.
Seminars in Arthritis and Rheumatism
|
July 23, 2016
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
Christina Charles-Schoeman, Pierre Wicker, Miguel A Gonzalez-Gay, et al.
Journal of the American College of Cardiology
|
April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study
James Shepherd, John J P Kastelein, Vera Bittner, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study
James Shepherd, John J P Kastelein, Vera Bittner, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Pediatric and Adolescent Gynecology
|
December 15, 2016
Clinical Recommendation: Vulvovaginitis
Andrea Zuckerman, Mary Romano
The American Journal of Geriatric Pharmacotherapy
|
August 5, 2008
Cardiovascular risk factors and dementia
Howard Fillit, David T Nash, Tatjana Rundek, et al.
Journal of the Cardiometabolic Syndrome
|
September 6, 2007
Atorvastatin does not induce glomerular or tubular dysfunction even at high doses
Murray Epstein, Elizabeth Leary, Rachel Laskey, et al.
Journal of the American Society of Nephrology : JASN
|
July 23, 2003
Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP
Praveen N Chander, Ricardo Rocha, Jeffrey Ranaudo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 14, 2009
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD
Michael J Koren, Michael H Davidson, Daniel J Wilson, et al.
Fertility and Sterility
|
September 28, 2021
Iconic brands: standing the test of time with a little rebranding
Steven R Lindheim, Samantha M Pfeifer, Beth W Rackow, et al.
Seminars in Arthritis and Rheumatism
|
April 16, 2016
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist
Christina Charles-Schoeman, Miguel A Gonzalez-Gay, Irina Kaplan, et al.
Seminars in Arthritis and Rheumatism
|
July 23, 2016
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
Christina Charles-Schoeman, Pierre Wicker, Miguel A Gonzalez-Gay, et al.
Journal of the American College of Cardiology
|
April 12, 2008
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study
James Shepherd, John J P Kastelein, Vera Bittner, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 19, 2007
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study
James Shepherd, John J P Kastelein, Vera Bittner, et al.
Page
of 2